Researchers may have found a new way to weaken glioblastoma’s defenses against treatment. Blocking a protein called SET prevented tumors from forming in preclinical models, while targeting related proteins made cancer cells more vulnerable to radiation. The strategy works by restoring activity of PP2A, an enzyme that glioblastoma cells appear to suppress. Human testing will be needed to determine whether the approach is safe and effective.
More in Research
Popular brain supplement linked to shorter lifespan in men
September 6, 2026
Scientists find breast cancer cells hiding behind protective “shields”
September 6, 2026
This lifestyle program improved cognition 55% more than basic health advice
September 6, 2026
Scientists discover a hidden problem with this popular sugar substitute
September 6, 2026
Indonesia’s most dangerous fires are burning underground
September 6, 2026
AI can now control fusion plasma faster than humans can react
September 6, 2026
Latest News
3 years on, Morocco earthquake victims still wait for help
September 7, 2026
Top Honour For Goa Police As Amit Shah Presents President's Colour
September 7, 2026
Tigress Tranquilised After Killing 4, Dies On Way To Rescue Centre
September 7, 2026
GTA 6 Will Launch Digitally at Midnight Around the World, So Of Course Fans Are Already Planning to Set Their Console Locations to New Zealand
September 7, 2026
Blood Dungeon Is A Survivors-Like For People Who Don’t Like Vampire Survivors
September 7, 2026
Man Kills Wife In Guwahati, Chops Fingers, Stores Severed Head In Fridge
September 7, 2026